IPO Timeline
Broker Results (T-2)
2021-07-06
Some brokers release in afternoon
Grey Market (T-1)
2021-07-07
Afternoon
HKEX Allotment (T-1)
2021-07-07
Evening
Registrar Allotment (T-1)
2021-07-07
Evening
Listing Day (T)
2021-07-08
First day of trading
Company Overview
| Stock Name | 康諾亞生物醫藥科技有限公司 - B |
|---|---|
| Stock Code | 02162 |
| Company Full Name | 康諾亞生物醫藥科技有限公司 - B |
| Industry | 醫療保健 |
| Principal Activities | 主要從事生物制藥業務，治療領域為自體免疫及腫瘤。 |
| Listing Date | 2021-07-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國四川省成都天府國際生物城生物城中路18號D2棟 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.keymedbio.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 53.30 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 47.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 1,552,788,900 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 68.0 |
|---|---|
| First Day Open | HK$ 78.0 |
| First Day Change | 27.58% |
| First Day Volume | 42544600.0 |
| First Day Turnover | 3004370000.0 |
Use of Proceeds
| Use of Proceeds | 1、約60%，或1765.20百萬港元，于未來三至五年內，將主要用于核心及主要產品的研發及商業化； 2、約15%，或441.30百萬港元，將用于我們其他在研產品的臨床前評估及臨床開發； 3、約15%，或441.30百萬港元，將用于我們新生產及研發設施的租賃付款，及購買機械及設備； 4、約10%，或294.20百萬港元將用于我們的一般企業及營運資金用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (3)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
华泰金融控股（香港）有限公司 CE AOK809
Overall Coordinators (3)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
华泰金融控股（香港）有限公司 CE AOK809
Joint Bookrunners (4)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
华泰金融控股（香港）有限公司 CE AOK809
中国光大证券（香港）有限公司 CE AAW536
Joint Lead Managers (4)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
华泰金融控股（香港）有限公司 CE AOK809
中国光大证券（香港）有限公司 CE AAW536
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Aranda Investments Pte. Ltd. | 116,433,850 HKD | — | 3.75% | — | 6 months | 2022-01-08 |
| 2 | Boyu Capital Opportunities Master Fund | 77,631,450 HKD | — | 2.50% | — | 6 months | 2022-01-08 |
| 3 | Double Joy Ventures Limited | 77,631,450 HKD | — | 2.50% | — | 6 months | 2022-01-08 |
| 4 | Hillhouse Funds | 116,433,850 HKD | — | 3.75% | — | 6 months | 2022-01-08 |
| 5 | Hudson Bay Master Fund LTD | 38,802,400 HKD | — | 1.25% | — | 6 months | 2022-01-08 |
| 6 | Invesco Advisers, Inc. | 310,525,800 HKD | — | 10.00% | — | 6 months | 2022-01-08 |
| 7 | Janchor Partners Pan-Asian Master Fund | 38,802,400 HKD | — | 1.25% | — | 6 months | 2022-01-08 |
| 8 | Lake Bleu Prime Healthcare Master Fund Limited | 77,631,450 HKD | — | 2.50% | — | 6 months | 2022-01-08 |
| 9 | LAV Fund VI | 77,631,450 HKD | — | 2.50% | — | 6 months | 2022-01-08 |
| 10 | Octagon Investments Master Fund LP | 38,802,400 HKD | — | 1.25% | — | 6 months | 2022-01-08 |
| 11 | Sage Partners Master Fund | 38,802,400 HKD | — | 1.25% | — | 6 months | 2022-01-08 |
| 12 | Springhill Master Fund Limited | 38,802,400 HKD | — | 1.25% | — | 6 months | 2022-01-08 |
| 13 | UBS Asset Management (Singapore) Ltd. | 310,525,800 HKD | — | 10.00% | — | 6 months | 2022-01-08 |
| 14 | Yi Fang Da Sirius Inv. Limited | 38,802,400 HKD | — | 1.25% | — | 6 months | 2022-01-08 |
| 15 | 佳曦控股有限公司 | 77,631,450 HKD | — | 2.50% | — | 6 months | 2022-01-08 |
Directors & Management
| Chairman | Bo CHEN |
|---|---|
| Company Secretary | 譚栢如 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Chen Bo及關連人士(27.86%);高瓴資本管理有限公司(9.26%);Boyu Capital Group Holdings Ltd(5.39%) |
|---|
IPO Timeline
